However, an analysis of data from the Vitamin D and Omega-3 Trial (VITAL) found, among 1,032 participants with migraines, those who received 2,000 IU (50 mcg) vitamin D3 per day reported no changes in migraine frequency or severity compared with placebo during almost five years of treatment (Rist 2021)
Each ingredient has been academically studied for its unique properties, and when combined, they provide researchers with opportunities to evaluate potential complementary pathways in controlled invitro environments
Balenovic D, Bencic ML, Udovicic M, et al
Li, F., Yang, H., Duan, Y
We do not use any fillers in this process.
Women, Work, and the COVID Pandemic: Myths and Realities